AVE 0.00% 0.3¢ avecho biotechnology limited

Shareholder Email 19 December 2023, page-15

  1. 4,461 Posts.
    lightbulb Created with Sketch. 8612
    I think you're kicking your own can of cognitive dissonance down the road

    the numbers are correct and align with the empirical evidence of Epidiolex - the only DEA / FDA registered cbd on the market -that data is available to all and free of misinterpretation or opinion
    combined with TPM#3 demonstrating a x4 treatment profile improvement and you have the opportunity where others have fallen short

    Epidiolex:
    https://hotcopper.com.au/data/attachments/5867/5867387-f8f0b7535f8c21c1851a4f9eef29c420.jpg
    red or black
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.